BPG is committed to discovery and dissemination of knowledge
Review
©The Author(s) 2025.
World J Gastroenterol. Nov 14, 2025; 31(42): 111291
Published online Nov 14, 2025. doi: 10.3748/wjg.v31.i42.111291
Table 4 Real-life recommendations of world-wide major associations[148-153]
Organization
Starting age
Screening methods
Interval
AI integration/position
American Cancer Society45Colonoscopy, stool-based (FIT/FIT-DNA), CT-colonographyColonoscopy: 10 years; FIT: Annually; FIT-DNA: Every 3-yearsSupports emerging AI technologies in clinical research and potential guideline updates
American Gastroenterological Association45Colonoscopy preferred; other options acceptable for shared decision-makingBased on methodDraft guidelines recommend AI-assisted colonoscopy (CADe) as a quality enhancing tool
European Society of Gastrointestinal Endoscopy50 (varies by country)FIT-based programs, colonoscopy in select settingFIT: Every two years; colonoscopy: Every ten yearsEncourages integration of CADe systems in clinical practice to improve adenoma detection rates
National Comprehensive Cancer Network45Colonoscopy, stool-based tests, CT colonographyColonoscopy: Ten years; FIT/FIT-DNA: Per testSupports AI use for colonoscopy enhancement particularly in high-risk population
World Health Organization50 (resource dependent)FIT-based screening for population level programsFIT: Every two yearsRecognizes potential role of AI in expanding access and accuracy in low-resource setting; encourages cost-effective AI research
Japanese Society of Gastroenterology40 (or even earlier for workplace health checks)FITFIT: AnnuallyJapan’s first major AI-colonoscopy system, EndoBRAIN, received regulatory approval and reimbursement starting in 2024
Food and Drug Administration45 (earlier initiation for those with higher risk factors)Colonoscopy, FIT, stool DNA-FIT, CT colonography, flexible sigmoidoscopyColonoscopy: Every ten years; FIT: Annually; Stool DNA-FIT: Every 1-3 years; CT colonography: Every five years; Flexible sigmoidoscopy: Every 5-10 yearsFDA has cleared CADe systems for real-time detection assistance during colonoscopy, but explicitly prohibits there use for lesion diagnosis or automated clinical decision making


Write to the Help Desk